Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Barrett Esophagus × obeticholic acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Duodenal Neoplasms 1 Colorectal Neoplasms 1 Barrett Esophagus 1 Attenuated familial adenomatous polyposis 1 Adenomatous Polyposis Coli 1 Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 2 Endoscopy, Digestive System 2 Endoscopy 2 Biopsy 2 Aspirin 2 polyphenon E 1 obeticholic acid 1 Radiofrequency Ablation 1 Metformin 1 Itraconazole 1 Genetic Linkage 1 Gastroscopy 1 Esomeprazole 1 Erlotinib Hydrochloride 1 Comparative Genomic Hybridization 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04939051 2026-03-18

Obeticholic Acid for Prevention in Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡